FDA approves first generic Naloxone nasal spray to reverse opioid overdoses

WASHINGTON, DC - OCTOBER 25: Dr. Nora Volkow, director at the National Institute on Drug Abuse (NIDA) and National Institutes of Health (NIH), holds up a narcan nasal spray (naloxone) (Photo by Drew Angerer/Getty Images)

The Food and Drug Administration has approved the first generic nasal spray to reverse the effects of opioids.

Generic Naloxone has been available for years in an injectable form, but this would be the first nasal spray.

Anyone can use it, even without training.

According to the Centers for Disease Control and Prevention, more than 130 Americans die every day from overdoses involving opioids.

TRENDING NOW: